Epigenetic resensitization to platinum in recurrent, platinum-resistant ovarian cancer (OC) using guadecitabine (SGI-110), a novel hypomethylating agent (HMA): Results of a randomized phase II study.

Ursula A. Matulonis, Daniela Matei, Diane Provencher et al.|Journal of Clinical Oncology|2016

Cited by 8